Clinical Trials Directory

Trials / Completed

CompletedNCT02386163

Large-scale ex Vivo Expansion and Characterization of Two Kinds of MSC From Knee for Clinical Application

Large-scale ex Vivo Expansion and Characterization of Synovial Membrane MSC (SM-MSC) and Infrapatellar Fat Pad MSC (IF-MSC) for Clinical Application

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
EMO Biomedicine Corporation · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

According to many researches, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis. Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of TKR (Total Knee Replacement). The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare their characterization and potential for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)".

Conditions

Interventions

TypeNameDescription
BIOLOGICALMSC from synovial membrane and infrapatellar Fat Pad

Timeline

Start date
2014-05-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2015-03-11
Last updated
2015-09-10

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02386163. Inclusion in this directory is not an endorsement.

Large-scale ex Vivo Expansion and Characterization of Two Kinds of MSC From Knee for Clinical Application (NCT02386163) · Clinical Trials Directory